Skip to main content
. 2023 Dec 4;161(4):380–387. doi: 10.1093/ajcp/aqad161

TABLE 2.

Patient Treatment and Outcomes

Characteristic No. (%)
Treatment
 Observation onlya 22 (32.9)
 Observation followed by treatment 7 (10.0)
 Surgery only 1 (1.4)
 Radiation 5 (7.1)
 Low-intensity chemotherapy 18 (25.7)
 Aggressive chemotherapy 16 (23.0)
 Unknown 1 (1.4)
Outcome
 Transformation 9 (12.9)
 DLBCL 6 (8.6)
 Blastoid B-cell neoplasm 1 (1.4)
 Unknown 2 (2.8)
 Death 14 (20.0)
 4-year OS 63 (90.0)

DLBCL, diffuse large B-cell lymphoma; OS, overall survival.

aIncludes 1 patient treated for hepatitis C.